| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |